Clinical Trials Directory

Trials / Completed

CompletedNCT00636389

Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers

Urea, Phosphate and b2-Microglobulin Removal and Ease of Use: Comparing the Polyflux HD-C4 With the Polyflux 210H

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Vantive Health LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Polyflux HD-C4 (Gambro Renal Products) is a new dialyzer based on the existing Polyflux H membrane and dialyzer technology, but which achieves a performance comparable to Polyflux 210H in a significantly smaller device. The objectives of this study are: 1. To compare and contrast small and large molecule removal by the Polyflux HD-C4 and Polyflux 210H dialyzers under conditions of routine hemodialysis; and, 2. To compare and contrast the ease of use of the Polyflux HD-C4 dialyzer with that of the Polyflux 210H under conditions of routine clinical use for hemodialysis.

Conditions

Interventions

TypeNameDescription
DEVICEPolyflux 210H dialyzerThree consecutive treatments with the Polyflux 210H dialyzer. All study treatments will be performed in the standard hemodialysis mode.
DEVICEPolyflux HD-C4Three consecutive treatments with the Polyflux HD-C4 dialyzer. All study treatments will be performed in the standard hemodialysis mode.

Timeline

Start date
2008-02-01
Primary completion
2008-12-01
Completion
2009-03-01
First posted
2008-03-14
Last updated
2025-07-14
Results posted
2011-08-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00636389. Inclusion in this directory is not an endorsement.